Background
The burden of antibiotic misuse
Health economics consequences
Antibiotics in respiratory tract infections and sepsis
Limitations of current diagnostic tools
The TAILORED-treatment project
Study objectives
Primary objective
Secondary objectives
Methods
General study design
Study participants
Inclusion criteria | Exclusion criteria |
---|---|
Age ≥ 1 month | Proven or suspected HIV, HBV, or HCV infection |
Symptoms ≤8 days | Post-transplant |
LRTI; ≥ 2 signs
| Congenital immune deficiency |
Respiratory rate > 20/mina | Obvious alternative causes of respiratory distress |
Chest cough | Nosocomial LRTI (> 3 days after hospitalization) |
Nasal flaring | Other febrile infection during the past 3 weeks |
Retractions | Active (haematological) malignancy |
Rales | Immune-suppressive or immune-modulating therapies |
Expiratory wheeze | Moderate to severe psychomotor retardation |
Decreased breath sounds | Moderate to severe congenital metabolic disorder |
Sepsis
b
; ≥ 2 signs
c
| |
Heartrate > 90/min | |
Respiratory rate > 20/min | |
Core body temperature > 38 °C or < 36 °C | |
White blood cell count > 12,000 cells/ μl or < 4000/ μl |